{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:34:38Z","timestamp":1785465278687,"version":"3.56.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. Complications of NOAF include thromboembolic events such as myocardial infarction and stroke, which contribute to a greater risk of mortality. Inflammatory and coagulation biomarkers in sepsis are thought to be associated with NOAF development. The aim of this systematic review and narrative synthesis is to identify inflammatory and coagulation biomarkers as predisposing risk factors for NOAF in sepsis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Three databases (Medline, Cochrane Library, and Scopus) were searched using a predefined search strategy. Inclusion \/ exclusion criteria were applied, and quality assessments were performed using the Newcastle Ottawa Scale (NOS).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>We identified 1776 articles; and 12 articles were included in this review. 8 articles were retrospective observational studies and 4 were prospective observational studies. There was considerable heterogeneity between studies regarding outcomes, methodological design, quality, definitions and reported biomarkers of interest. There is evidence that C-reactive protein (CRP) is associated with NOAF, with hazard ratios 3.33 (3.32\u20133.35) p = 0.001 and odds ratios of 1.011 (1.008\u20131.014) p&lt;0.001. International Normalised Ratio (INR) and fibrinogen may be associated with NOAF with odds ratios reported as 1.837 (1.270\u20132.656) p = 0.001 and 1.535(1.232\u20131.914) p&lt;0.001 respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Further research is required to confirm the association between inflammatory and coagulation biomarkers and the development of NOAF in sepsis. A broader evidence base will guide treatment strategies, improving the standard of care for patients who develop NOAF in sepsis. Furthermore, given the heterogeneity between studies consideration should be given to inclusion of immune biomarkers in future core outcome sets for trials investigating NOAF.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0318365","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:27:32Z","timestamp":1738175252000},"page":"e0318365","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-3297","authenticated-orcid":true,"given":"Brian W.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4139-191X","authenticated-orcid":true,"given":"Michael","family":"Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg D.","family":"Welters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"issue":"7","key":"pone.0318365.ref001","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00134-019-05633-x","article-title":"New-onset atrial fibrillation in adult critically ill patients: a scoping review.","volume":"45","author":"M Wetterslev","year":"2019","journal-title":"Intensive Care Medicine"},{"issue":"1","key":"pone.0318365.ref002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40635-022-00490-3","article-title":"A deep learning model for the classification of atrial fibrillation in critically ill patients.","volume":"11","author":"B Chen","year":"2023","journal-title":"Intensive Care Medicine Experimental"},{"issue":"6","key":"pone.0318365.ref003","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.chest.2018.03.040","article-title":"Atrial Fibrillation in the ICU.","volume":"154","author":"NA Bosch","year":"2018","journal-title":"Chest."},{"issue":"3","key":"pone.0318365.ref004","doi-asserted-by":"crossref","first-page":"e034774","DOI":"10.1136\/bmjopen-2019-034774","article-title":"Managing new-onset atrial fibrillation in critically ill patients: a systematic narrative review","volume":"10","author":"O Liam Joseph","year":"2020","journal-title":"BMJ Open"},{"key":"pone.0318365.ref005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcrc.2019.06.015","article-title":"Risk factors for new-onset atrial fibrillation on the general adult ICU: A systematic review","volume":"53","author":"JP Bedford","year":"2019","journal-title":"Journal of Critical Care"},{"issue":"9","key":"pone.0318365.ref006","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes","volume":"120","author":"L Staerk","year":"2017","journal-title":"Circ Res"},{"issue":"4","key":"pone.0318365.ref007","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12040547","article-title":"Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis.","volume":"12","author":"B Corica","year":"2022","journal-title":"J Pers Med."},{"issue":"1","key":"pone.0318365.ref008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13054-020-2730-0","article-title":"New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults-a multicenter retrospective cohort study.","volume":"24","author":"SM Fernando","year":"2020","journal-title":"Crit Care"},{"issue":"20","key":"pone.0318365.ref009","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1001\/jama.2011.1615","article-title":"Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis","volume":"306","author":"AJ Walkey","year":"2011","journal-title":"JAMA"},{"issue":"8","key":"pone.0318365.ref010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ehjacc\/zuac080","article-title":"New-onset atrial fibrillation in intensive care: epidemiology and outcomes","volume":"11","author":"JP Bedford","year":"2022","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"1","key":"pone.0318365.ref011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of Atrial Fibrillation in the 21st","volume":"127","author":"J Kornej","year":"2020","journal-title":"Century. Circulation Research"},{"issue":"3","key":"pone.0318365.ref012","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.chest.2019.04.011","article-title":"Long-Term Impact of Newly Diagnosed Atrial Fibrillation During Critical Care: A South Korean Nationwide Cohort Study.","volume":"156","author":"K Kim","year":"2019","journal-title":"Chest."},{"key":"pone.0318365.ref013","article-title":"Critical illness associated new onset atrial fibrillation: subsequent atrial fibrillation diagnoses and other adverse outcomes.","author":"D Lancini","year":"2022","journal-title":"EP Europace."},{"key":"pone.0318365.ref014","doi-asserted-by":"crossref","first-page":"1144229","DOI":"10.3389\/fimmu.2023.1144229","article-title":"Endothelial dysfunction and immunothrombosis in sepsis.","volume":"14","author":"E Maneta","year":"2023","journal-title":"Front Immunol"},{"issue":"11","key":"pone.0318365.ref015","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1111\/jth.15852","article-title":"Intracellular communication and immunothrombosis in sepsis","volume":"20","author":"T Iba","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"1","key":"pone.0318365.ref016","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12916-015-0327-2","article-title":"Causes and consequences of coagulation activation in sepsis: an evolutionary medicine perspective.","volume":"13","author":"MML Fiusa","year":"2015","journal-title":"BMC Medicine."},{"issue":"10","key":"pone.0318365.ref017","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.molmed.2011.05.007","article-title":"Inflammatory pathways underlying atrial fibrillation","volume":"17","author":"K Friedrichs","year":"2011","journal-title":"Trends in Molecular Medicine"},{"issue":"9","key":"pone.0318365.ref018","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"K Stark","year":"2021","journal-title":"Nature Reviews Cardiology"},{"issue":"36","key":"pone.0318365.ref019","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"TA Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0318365.ref020","article-title":"The association of coagulation and atrial fibrillation: a systematic review and meta-analysis.","volume":"euac130","author":"MJ Tilly","year":"2022","journal-title":"EP Europace."},{"key":"pone.0318365.ref021","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1230854","article-title":"Sepsis-induced coagulopathy is associated with new episodes of atrial fibrillation in patients admitted to critical care in sinus rhythm.","volume":"10","author":"S Ortega-Martorell","year":"2023","journal-title":"Frontiers in Medicine."},{"key":"pone.0318365.ref022","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"Bmj"},{"key":"pone.0318365.ref023","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"Bmj"},{"issue":"9","key":"pone.0318365.ref024","doi-asserted-by":"crossref","first-page":"e0290963","DOI":"10.1371\/journal.pone.0290963","article-title":"Study protocol: A systematic review and meta-analysis regarding the influence of coagulopathy and immune activation on new onset atrial fibrillation in patients with sepsis.","volume":"18","author":"M Downes","year":"2023","journal-title":"PLoS One"},{"key":"pone.0318365.ref025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2046-4053-1-5","article-title":"The importance of PROSPERO to the National Institute for Health Research","volume":"1","author":"S. Davies","year":"2012","journal-title":"Syst Rev"},{"key":"pone.0318365.ref026","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2046-4053-1-7","article-title":"Why prospective registration of systematic reviews makes sense.","volume":"1","author":"L Stewart","year":"2012","journal-title":"Syst Rev"},{"key":"pone.0318365.ref027","year":"2023","journal-title":"MEDLINE (Ovid) database"},{"key":"pone.0318365.ref028","year":"2023","journal-title":"Scopus online database"},{"key":"pone.0318365.ref029","year":"2023","journal-title":"Cochrane Library Online Database"},{"issue":"10","key":"pone.0318365.ref030","first-page":"986","article-title":"Differences between adult and pediatric septic shock","volume":"77","author":"RK Aneja","year":"2011","journal-title":"Minerva Anestesiol"},{"key":"pone.0318365.ref031","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1875041901104010004","article-title":"Pediatric Sepsis\u2014Part I: \"Children are not small adults!\".","volume":"4","author":"DS Wheeler","year":"2011","journal-title":"Open Inflamm J"},{"issue":"8","key":"pone.0318365.ref032","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).","volume":"315","author":"M Singer","year":"2016","journal-title":"Jama"},{"issue":"9","key":"pone.0318365.ref033","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"A. Stang","year":"2010","journal-title":"European Journal of Epidemiology"},{"issue":"5","key":"pone.0318365.ref034","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions","volume":"64","author":"JL Brozek","year":"2009","journal-title":"Allergy"},{"issue":"7","key":"pone.0318365.ref035","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jiph.2022.06.006","article-title":"Secondary bacterial infections are a leading factor triggering New Onset Atrial Fibrillation in intubated ICU Covid-19 ARDS patients","volume":"15","author":"GE Zakynthinos","year":"2022","journal-title":"Journal of Infection and Public Health"},{"issue":"6","key":"pone.0318365.ref036","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/SHK.0000000000000673","article-title":"Association of heart rate with n-terminal pro-B-type Natriuretic peptide in septic patients: A prospective observational cohort study","volume":"46","author":"N Hayase","year":"2016","journal-title":"Shock"},{"issue":"4","key":"pone.0318365.ref037","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jcrc.2014.03.029","article-title":"Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patients","volume":"29","author":"SS Makrygiannis","year":"2014","journal-title":"Journal of Critical Care"},{"issue":"3","key":"pone.0318365.ref038","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/cc9057","article-title":"Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study","volume":"14","author":"R Meierhenrich","year":"2010","journal-title":"Crit Care"},{"key":"pone.0318365.ref039","first-page":"9","article-title":"Development and validation of a predictive model for new-onset atrial fibrillation in sepsis based on clinical risk factors","author":"Z Li","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"pone.0318365.ref040","doi-asserted-by":"crossref","first-page":"107736","DOI":"10.1016\/j.intimp.2021.107736","article-title":"Association of monocyte-lymphocyte ratio with in-hospital mortality in cardiac intensive care unit patients","volume":"96","author":"G Zhai","year":"2021","journal-title":"International Immunopharmacology"},{"issue":"1","key":"pone.0318365.ref041","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jinf.2020.11.005","article-title":"New-onset atrial fibrillation in patients with pneumococcal pneumonia. Impact of timing and duration on short- and medium-term mortality","volume":"82","author":"LA Ruiz","year":"2021","journal-title":"Journal of Infection"},{"key":"pone.0318365.ref042","first-page":"8","article-title":"Early Coagulation Disorder Is Associated With an Increased Risk of Atrial Fibrillation in Septic Patients.","author":"Y Long","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine."},{"issue":"2","key":"pone.0318365.ref043","doi-asserted-by":"crossref","first-page":"20200457","DOI":"10.4022\/jafib.20200457","article-title":"Incidence and Prognostic Impact of New-Onset Atrial Fibrillation in Patients with Severe Covid-19: A Retrospective Cohort Study.","volume":"14","author":"R.JS Kanthasamy V","year":"2021","journal-title":"J Atr Fibrillation."},{"key":"pone.0318365.ref044","doi-asserted-by":"crossref","first-page":"1076029620932228","DOI":"10.1177\/1076029620932228","article-title":"Procalcitonin as a Marker of Comorbid Atrial Fibrillation in Chronic Kidney Disease and History of Sepsis.","volume":"26","author":"J Bontekoe","year":"2020","journal-title":"Clinical and Applied Thrombosis\/Hemostasis."},{"key":"pone.0318365.ref045","doi-asserted-by":"crossref","first-page":"105692","DOI":"10.1016\/j.intimp.2019.105692","article-title":"The neutrophil-lymphocyte ratio: A promising predictor of mortality in coronary care unit patients\u2014A cohort study","volume":"74","author":"H Sun","year":"2019","journal-title":"International Immunopharmacology"},{"issue":"3","key":"pone.0318365.ref046","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000121600","article-title":"New-Onset Atrial Fibrillation in Bacteremia Is Not Associated with C-Reactive Protein, but Is an Indicator of Increased Mortality during Hospitalization.","volume":"111","author":"IA Kindem","year":"2008","journal-title":"Cardiology."},{"issue":"5","key":"pone.0318365.ref047","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation: Analysis and Implications","volume":"155","author":"WM Feinberg","year":"1995","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"pone.0318365.ref048","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"AD Krahn","year":"1995","journal-title":"Am J Med"},{"issue":"8","key":"pone.0318365.ref049","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/pace.14301","article-title":"New-onset atrial fibrillation incidence and associated outcomes in the medical intensive care unit","volume":"44","author":"R Brunetti","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"pone.0318365.ref050","doi-asserted-by":"crossref","first-page":"897709","DOI":"10.3389\/fcvm.2022.897709","article-title":"Development of a Risk Prediction Model for New Episodes of Atrial Fibrillation in Medical-Surgical Critically Ill Patients Using the AmsterdamUMCdb.","volume":"9","author":"S Ortega-Martorell","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"pone.0318365.ref051","first-page":"179","article-title":"Predisposing factors for atrial fibrillation in the elderly.","volume":"14","author":"K Wasmer","year":"2017","journal-title":"J Geriatr Cardiol"},{"issue":"1","key":"pone.0318365.ref052","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12872-021-01978-8","article-title":"Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction","volume":"21","author":"Y Fu","year":"2021","journal-title":"BMC Cardiovascular Disorders"},{"issue":"24","key":"pone.0318365.ref053","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-Reactive Protein Elevation in Patients With Atrial Arrhythmias","volume":"104","author":"MK Chung","year":"2001","journal-title":"Circulation"},{"key":"pone.0318365.ref054","doi-asserted-by":"crossref","first-page":"862164","DOI":"10.3389\/fphys.2022.862164","article-title":"Role of Inflammation in the Pathogenesis of Atrial Fibrillation.","volume":"13","author":"K Ihara","year":"2022","journal-title":"Front Physiol"},{"issue":"5","key":"pone.0318365.ref055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.14503\/THIJ-13-3466","article-title":"Inflammation and C-reactive protein in atrial fibrillation: cause or effect?","volume":"41","author":"R Galea","year":"2014","journal-title":"Tex Heart Inst J."},{"issue":"2","key":"pone.0318365.ref056","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5551\/jat.54064","article-title":"Serum High-Sensitivity C-Reactive Protein Levels and the Risk of Atrial Fibrillation in Japanese Population: the Circulatory Risk in Communities Study","volume":"28","author":"M Tanaka","year":"2021","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"pone.0318365.ref057","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2796.2012.02531.x","article-title":"A functional variant in the promoter region regulates the C-reactive protein gene and is a potential candidate for increased risk of atrial fibrillation","volume":"272","author":"SN Chang","year":"2012","journal-title":"J Intern Med"},{"issue":"6","key":"pone.0318365.ref058","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1085\/jgp.201912338","article-title":"How Ca2+ influx is attenuated in the heart during a \u201cfight or flight\u201d response.","volume":"151","author":"M Bazmi","year":"2019","journal-title":"Journal of General Physiology"},{"issue":"2","key":"pone.0318365.ref059","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/hrt.2006.108688","article-title":"The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation","volume":"94","author":"EM Kallergis","year":"2008","journal-title":"Heart"},{"issue":"2","key":"pone.0318365.ref060","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/clc.20290","article-title":"Inflammation in lone atrial fibrillation","volume":"32","author":"SY Yao","year":"2009","journal-title":"Clin Cardiol"},{"issue":"7","key":"pone.0318365.ref061","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/1076029618772353","article-title":"International Normalized Ratio Relevance to the Observed Coagulation Abnormalities in Warfarin Treatment and Disseminated Intravascular Coagulation.","volume":"24","author":"A Walborn","year":"2018","journal-title":"Clin Appl Thromb Hemost."},{"issue":"1","key":"pone.0318365.ref062","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.amjcard.2006.01.067","article-title":"Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study).","volume":"98","author":"KJ Mukamal","year":"2006","journal-title":"Am J Cardiol"},{"issue":"12","key":"pone.0318365.ref063","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2165\/11633140-000000000-00000","article-title":"Drug-induced atrial fibrillation.","volume":"72","author":"Y Kaakeh","year":"2012","journal-title":"Drugs."},{"issue":"6","key":"pone.0318365.ref064","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.CCM.0000166876.41694.CA","article-title":"\"Renal dose\" dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery.","volume":"33","author":"M Argalious","year":"2005","journal-title":"Crit Care Med"},{"issue":"10","key":"pone.0318365.ref065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4066\/AMJ.2011.761","article-title":"Dopamine versus noradrenaline in septic shock","volume":"4","author":"B Xu","year":"2011","journal-title":"Australas Med J"},{"key":"pone.0318365.ref066","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajem.2020.12.062","article-title":"Outcomes of new-onset atrial fibrillation in patients with sepsis: A systematic review and meta-analysis of 225,841 patients","volume":"42","author":"F-p Xiao","year":"2021","journal-title":"The American Journal of Emergency Medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:27:59Z","timestamp":1738175279000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318365"}},"subtitle":[],"editor":[{"given":"Chiara","family":"Lazzeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0318365","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}